[8-K] PURE BIOSCIENCE, INC. Reports Material Event

Rhea-AI Filing Summary

PURE Bioscience, Inc. announced a leadership change in its executive team. Jeffrey Kitchell has been appointed as the company’s President, effective November 17, 2025, while continuing in his existing role as Corporate Secretary. Robert Bartlett remains Chief Executive Officer, principal executive officer, and a member of the board, but no longer holds the President title.

Kitchell, age 55, has been Vice President of Operations since April 2023 and has served as Corporate Secretary since 2019. He has been with the company since 2001 in a variety of roles overseeing day-to-day operations, legal affairs, and intellectual property, and holds a Bachelor’s degree in Business Administration from the University of Phoenix. His compensation terms are expected to follow the company’s standard officer indemnification and benefit programs, with no new special arrangements or related-party relationships disclosed.

false 0001006028 0001006028 2025-11-17 2025-11-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 17, 2025

PURE BIOSCIENCE, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-14468		33-0530289
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

771 Jamacha Rd., #512 El Cajon, California		92019
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (619) 596-8600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 19, 2025, PURE Bioscience, Inc. (the “Company”) announced that Jeffrey Kitchell has been appointed as the Company’s President, in addition to his ongoing responsibilities as the Company’s Corporate Secretary, effective as of November 17, 2025 (the “Effective Date”). Robert Bartlett will continue as the Company’s Chief Executive Officer, principal executive officer and a member of the Company’s board of directors, but stepped down from the position of President effective as of the Effective Date.

Mr. Kitchell, 55, has served as the Company’s Vice President of Operations since April 2023. He also serves as the Company’s Corporate Secretary, a role he has had since 2019. Mr. Kitchell oversees day-to-day operations, supports the Company’s functions, and implements new structures and processes. Mr. Kitchell has held various roles since joining the Company in 2001. In his various roles, he managed the Company’s legal affairs and helped secure its intellectual property. Before joining the Company, Mr. Kitchell held various leadership roles in companies ranging from small to large. Mr. Kitchell earned a Bachelor’s Degree in Business Administration from the University of Phoenix.

It is anticipated that Mr. Kitchell will enter into the Company’s standard form of indemnification agreement for the Company’s officers and participate in other compensation and benefit programs generally available to the Company’s executive officers. The terms of Mr. Kitchell’s employment with the Company otherwise remain unchanged.

Except as set forth above, there are no arrangements or understandings between Mr. Kitchell and any other persons pursuant to which he was named to this position with the Company. There are no family relationships between Mr. Kitchell and any of the Company’s directors or executive officers and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

The Company issued a press release announcing the appointment of Mr. Kitchell, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

99.1	Press Release, dated November 19, 2025.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	PURE BIOSCIENCE, INC.
Dated: November 19, 2025	By:	/s/ Robert F. Bartlett
		Robert F. Bartlett
		Chief Executive Officer

FAQ

What executive leadership change did PURE (PURE Bioscience, Inc.) announce?

PURE Bioscience, Inc. announced that Jeffrey Kitchell has been appointed as the company’s President, effective November 17, 2025, while continuing as Corporate Secretary.

What is Robert Bartlett’s role at PURE after the leadership change?

Robert Bartlett continues to serve as PURE’s Chief Executive Officer, principal executive officer, and a member of the board of directors, but he stepped down from the President position as of November 17, 2025.

What is Jeffrey Kitchell’s background at PURE Bioscience (PURE)?

Jeffrey Kitchell, age 55, has served as PURE’s Vice President of Operations since April 2023 and as Corporate Secretary since 2019. He joined the company in 2001 and has overseen operations, legal affairs, and intellectual property.

Will Jeffrey Kitchell receive any special compensation arrangements in his new role at PURE?

It is anticipated that Jeffrey Kitchell will enter into PURE’s standard officer indemnification agreement and participate in compensation and benefit programs generally available to executive officers. The terms of his employment otherwise remain unchanged.

Are there any family or related-party relationships involving Jeffrey Kitchell at PURE?

The company states there are no arrangements or understandings with other persons related to his appointment, no family relationships between Kitchell and any directors or executive officers, and no material interest in transactions requiring disclosure under Item 404(a) of Regulation S-K.

Did PURE issue a press release about Jeffrey Kitchell’s appointment as President?

Yes. PURE issued a press release dated November 19, 2025 announcing the appointment of Jeffrey Kitchell as President, which is identified as Exhibit 99.1.